More magazine and Editor-in-Chief Lesley Jane Seymour hosted the Reinvention Convention on May 17 in Chicago, bringing together more than 600 women interested in revitalizing their careers, finances, style and health.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/moremagazine/44308/
Team for Life - Fighting Cancer, Giving Hope
Lazarex Cancer Foundation (www.lazarex.org) is a 501(c)(3) non profit that was founded by Dana Dornsife, who is also President of the organization. She became a cancer advocate when her brother-in-law Mike was diagnosed with pancreatic cancer in 2003 as she searched for options that would buy Mike and his family some additional time. Her dedication enabled Mike to live long enough so that his youngest daughter would have real memories of him, which she could keep throughout her life
Dana & Jaiden Edelman
Father & Son duo on Martha\'s Vineyard
Shot/Directed and edited by Gerry Wenner
Location: The Yard, Chilmark, MA
https://itunes.apple.com/us/album/mas...
www.danaedelman.com
"Is This Real?" OFFICIAL MUSIC VIDEO
Performance recorded at JZ International Jazz Festival 2013 and edited by WITCH2ND
Written by Jay Dub, featuring Tia.Ray
Jay Dub (Jewell Fortenberry) on Lead Vocals
Soulspeak (Jeff Liang) as DJ
Theo Croker on Trumpet
Danimal (Dan Zylinski) on Bass
Fat Tony (Anthony Parker) on Drums
Xiao Yu on Background Vocals
Dana Shellmire on Background Vocals
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $40.3 million in new research investments to advance the most promising blood cancer science at leading academic and medical centers around the world, including Dana-Farber Cancer Institute in Boston; Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in New York; MD Anderson Cancer Center in Houston; Fondazione Centro San Raffaele in Milan; and South Australian Health & Medical Research Institute in Adelaide.
This $40.3 million investment, comprised of 75 new research grants in LLS’s portfolio of 300 projects, will fund a diverse array of research to find better treatments and cures for patients with leukemia, lymphoma, myeloma and other blood cancers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554855-lls-invests-millions-new-research-treatment-cures/
